Segment disclosures

Company overview

ENTRADA THERAPEUTICS, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 18 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=trda:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30905000 USD20261105Open filing evidence
2026-01-01 – 2026-09-302678000 USD20261105Open filing evidence
2026-04-01 – 2026-06-30898000 USD20260805Open filing evidence
2026-01-01 – 2026-06-301773000 USD20260805Open filing evidence
2026-01-01 – 2026-03-31875000 USD20260507Open filing evidence
2025-01-01 – 2025-12-3125421000 USD20260226Open filing evidence
2025-07-01 – 2025-09-301614000 USD20261105Open filing evidence
2025-01-01 – 2025-09-3024122000 USD20261105Open filing evidence
2025-04-01 – 2025-06-301950000 USD20260805Open filing evidence
2025-01-01 – 2025-06-3022508000 USD20260805Open filing evidence
2025-01-01 – 2025-03-3120558000 USD20260507Open filing evidence
2024-01-01 – 2024-12-31210782000 USD20260226Open filing evidence
2024-07-01 – 2024-09-3019570000 USD20251106Open filing evidence
2024-01-01 – 2024-09-30173384000 USD20251106Open filing evidence
2024-04-01 – 2024-06-3094694000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30153814000 USD20250806Open filing evidence
2024-01-01 – 2024-03-3159120000 USD20250508Open filing evidence
2023-01-01 – 2023-12-31129013000 USD20250227Open filing evidence